Nel ASA's Backlog Balloons to NOK 1.314 Billion as Revenue Dwindles — Leadership Transition Adds Another Variable

Nel ASA has a demand story and a delivery problem, and the gap between them is now the central question for anyone holding the stock. Fresh orders are pouring in, the backlog is climbing, and yet the money actually booked from customer contracts is shrinking fast. A management reshuffle announced in October has done little to settle which of those two forces will define the company's next chapter.

A quarter that pulls in two directions

The third-quarter 2026 figures, released roughly two weeks ago, lay out the split cleanly. Revenue from customer contracts fell 63% year on year to NOK 112 million. EBITDA came in at NOK -93 million, and the net loss reached NOK 141 million. Weakness on the top line, in other words, was matched by weakness at the operating level — this was not merely a revenue timing issue.

Order intake told the opposite story. New orders totaled NOK 253 million in the quarter, up 339% from a year earlier. The order backlog stood at NOK 1.314 million — NOK 1.314 billion — 34% above the prior-year level.

Those two sets of numbers describe different stages of the business. A backlog is a promise of future work; revenue is work already done and paid for. A larger book of orders does not by itself answer whether Nel can convert that pipeline into profitable turnover, and the persistent softness in its alkaline business further limits how much the order momentum can be read as a signal for the group as a whole.

Concrete business, and business that is only a possibility

Two announcements from around two weeks ago illustrate the distinction investors need to draw. The first was a firm order to Nel Hydrogen US covering several containerized PEM electrolysers plus associated services for an unnamed global US-based technology company. That contract carries a value of roughly USD 12 million, with delivery expected in 2027. It is real business — but it is business for next year, not a retroactive fix for the weak quarterly revenue.

The second was a memorandum of understanding with Rheinmetall, signed on 13 October. The two companies intend to explore decentralized production of low-carbon synthetic fuels, combining Nel's electrolyser technology with Rheinmetall's Giga-PtX concept. That agreement is explicitly exploratory. It is not a confirmed order, carries no binding revenue contribution, and belongs in a different category entirely from the US contract. Any upside from it would only take shape through further binding steps.

New faces at the top, same test at the bottom

Into this setting comes the leadership change. Nel has named Morten Holum to succeed Håkon Volldal as CEO, taking the role no later than 1 May 2027. The handover begins sooner: CFO Kjell Christian Bjørnsen becomes interim CEO from 1 November 2026, with Torbjørn Berg stepping in to run finance on a temporary basis.

A fresh face at the helm can help execution. It cannot substitute for proof that orders are turning into more business. The personnel decision leaves the core question exactly where it was.

Analysts have already turned more cautious. On 16 October, AlphaValue/Baader Europe cut its rating from "Buy" to "Accumulate," lowering the price target to NOK 2.38 from NOK 3.82. That downgrade is a warning sign rather than a verdict on how the business will actually perform — and like the management change, it should not stand in for a hard look at the operating numbers.

What would actually change the picture

The optimistic case rests on the one area where Nel has already reported improvement: orders. If the company can funnel its larger backlog into rising revenue and a lighter loss burden, the foundation for a genuine operating recovery would firm up — and the incoming leadership would inherit a stronger starting position. Add the Rheinmetall tie-up as a potential extra avenue, and the bull case becomes a combination of better order conversion plus possible new business, not the memorandum itself.

The bear case is a continued disconnect between bookings and revenue. In that scenario the bigger backlog remains a demand indicator and nothing more, and no change of CEO can paper over the missing proof. The loss trajectory is a serious counterweight to the order growth; a convincing recovery would need to show the company can ease its economic burden, not just collect more orders.

The next fixed date on the calendar is 1 November 2026, when the interim leadership takes over. That step concerns responsibility at the top of the company and does not yet demonstrate commercial success. What matters is whether revenue and losses improve under the transitional team and, later, under Holum. That is the yardstick against which any recovery case must be measured.